Home » Topics » Regulatory » Patents

Patents
RSS

New antiplatelet agents in the pipeline at Astra

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

DuPont discloses heteroaromatic factor Xa inhibitors

Oct. 22, 1998

NOS inhibitors developed at Chugai reportedly useful for cerebrovascular disorders

Oct. 22, 1998

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Oct. 21, 1998

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Oct. 21, 1998

Propionic acid derivatives from Nippon Chemiphar useful for diabetes and related disorders

Oct. 21, 1998

Cephems from Zenyaku Kogyo with improved activity compared to flomoxef, vancomycin

Oct. 21, 1998

Daiichi's new squalene synthase inhibitors

Oct. 21, 1998

Taisho describes antiischemic 2-phenoxyaniline derivatives

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.